Publikationen

Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023

Vaccines (Basel). 2024 Mar 8;12(3):284. doi: 10.3390/vaccines12030284.

PMID: 

Anita Siller, Lisa Seekircher, Manfred Astl, Lena Tschiderer, Gregor A Wachter, Julia Penz, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Cell Rep Med. 2024 Mar 19;5(3):101474. doi: 10.1016/j.xcrm.2024.101474.

PMID: 

Anass Abbad, Temima Yellin, Gagandeep Singh, Miriam Fried, Ariel Raskin, Johnstone Tcheou, Brian Monahan, Charles Gleason, PARIS Study Group, Viviana Simon, Juan Manuel Carreño, Florian Krammer

Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared with the reference standard-author’s reply

Clin Microbiol Infect. 2024 May;30(5):696-697. doi: 10.1016/j.cmi.2024.02.010. Epub 2024 Feb 14.

PMID: 

Helmut J F Salzer, Christoph Lange

Mycobacterium avium complex pulmonary disease patients with limited treatment options

ERJ Open Res. 2024 Jan 15;10(1):00610-2023. doi: 10.1183/23120541.00610-2023. eCollection 2024 Jan.

PMID: 

Stefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, Andrea Calcagno, Andreas Fløe, Dorothy Grogono, Apostolos Papavasileiou, Eva Polverino, Concepción Prados, Gernot Rohde, Helmut J F Salzer, Adrián Sánchez-Montalvá, Michal Shteinberg, Eva Van Braeckel, Jakko van Ingen, Nicolas Veziris, Dirk Wagner, Michael R Loebinger

Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease

Semin Respir Crit Care Med. 2024 Feb;45(1):102-113. doi: 10.1055/s-0043-1776913. Epub 2024 Jan 9.

PMID: 

Matthias J Neuböck, for CPAnet, Gunar Günther, Aleksandra Barac, Jesper R Davidsen, Christian B Laursen, Ritesh Agarwal, Inderpaul S Sehgal, Christoph Lange, Helmut J F Salzer

Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria

Eur J Clin Invest. 2024 Mar;54(3):e14136. doi: 10.1111/eci.14136. Epub 2023 Nov 30.

PMID: 

Alena Chalupka, Lukas Richter, Ali Chakeri, Ziad El-Khatib, Verena Theiler-Schwetz, Christian Trummer, Robert Krause, Peter Willeit, Bernhard Benka, John P A Ioannidis, Stefan Pilz

Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases

Curr Opin Pulm Med. 2024 Mar 1;30(2):156-166. doi: 10.1097/MCP.0000000000001026. Epub 2023 Oct 30.

PMID: 

Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, Helmut J F Salzer, Ritesh Agarwal

Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard

Clin Microbiol Infect. 2023 Dec;29(12):1605.e1-1605.e4. doi: 10.1016/j.cmi.2023.08.032. Epub 2023 Sep 7.

PMID: 

Helmut J F Salzer, Maja Reimann, Carolin Oertel, Jesper Rømhild Davidsen, Christian B Laursen, Eva Van Braeckel, Ritesh Agarwal, Korkut Avsar, Oxana Munteanu, Muhammed Irfan, Christoph Lange, CPAnet

Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19-experiences of a longitudinal series of 92 patients

Virchows Arch. 2023 Nov;483(5):611-619. doi: 10.1007/s00428-023-03622-6. Epub 2023 Sep 1.

PMID: 

Petar Noack, Claudia Grosse, Jacob Bodingbauer, Marion Almeder, Sylvia Lohfink-Schumm, Helmut J F Salzer, Jens Meier, Bernd Lamprecht, Clemens A Schmitt, Rupert Langer

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

Lancet Microbe. 2023 Aug;4(8):e612-e621. doi: 10.1016/S2666-5247(23)00107-6. Epub 2023 Jun 21.

PMID: 

Lisa Seekircher, Zoltán Bánki, Janine Kimpel, Annika Rössler, Helena Schäfer, Barbara Falkensammer, David Bante, Lukas Forer, Sebastian Schönherr, Shieldvacc-2 Study Group, Teresa Harthaller, Magdalena Sacher, Cornelia Ower, Lena Tschiderer, Hanno Ulmer, Florian Krammer, Dorothee von Laer, Wegene Borena, Peter Willeit
...9